In the SURMOUNT-1 trial, which evaluated tirzepatide in adults with obesity without diabetes, diarrhea occurred in approximately 21.2% of participants receiving 5 mg, 19.5% receiving 10 mg, and 23.0% receiving 15 mg weekly, compared to 7.3% in the placebo group
Frequently Asked Questions Can I inject my GLP-1 at different times each week
Clinical observations suggest that patients regain approximately 50 percent of their weight loss during the first year without continued treatment, though this varies widely depending on whether behavioral changesexercise habits, dietary awareness, portion controlremain in place
Several major platforms have adjusted pricing, changed their medication offerings, or shifted toward brand-name prescriptions as a result
Brands that align with the citys active lifestyle and growing population tend to perform particularly well